Research progress on the mechanism and treatment of epicardial adipose tissue and diabetes mellitus
GUO Zhendong1 TANG Hongxiu2 XIE Ping3
1.The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Gansu Province, Lanzhou 730030, China;
2.the First School of Clinical Medical of Lanzhou University, Gansu Province, Lanzhou 730030, China;
3.Department of Cardiology, Gansu Provincial Hospital, Gansu Province, Lanzhou 730030, China
Abstract Most people with diabetes are obese, presenting a low-grade proinflammatory state, and obesity increases insulin resistance and the risk of dyslipidemia, diabetes, and cardiovascular disease. At the same time, obesity can also lead to the thickening of epicardial adipose tissue (EAT), and there is increasing evidence that EAT is associated with an increased risk of diabetes. EAT is a kind of local deposit between myocardium and pericardium of viscera, and it is easy to measure visceral adipose tissue, its metabolic homeostasis plays an important role in the progression of diabetes. In recent years, new progress has been made in the research on the treatment strategy of diabetes and its influence on EAT. However, the exact role of EAT in the pathogenesis of diabetes needs further elucidation. In this paper, the molecular mechanism and therapeutic strategies of this disease are reviewed in order to provide clues for future research.
GUO Zhendong1 TANG Hongxiu2 XIE Ping3. Research progress on the mechanism and treatment of epicardial adipose tissue and diabetes mellitus[J]. 中国医药导报, 2023, 20(1): 33-39.
[1] Henning RJ. Type-2 diabetes mellitus and cardiovascular disease [J]. Future Cardiol，2018，14（6）：491-509.
[2] Saeedi P，Petersohn I，Salpea P，et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045：Results from the International Diabetes Federation Diabetes Atlas，9（th） edition [J]. Diabetes Res Clin Pract，2019，157：107843.
[3] Gaborit B，Sengenes C，Ancel P，et al. Role of Epicardial Adipose Tissue in Health and Disease：A Matter of Fat? [J]. Compr Physiol，2017，7（3）：1051-1082.
[4] Aitken-Buck HM，Moharram M，Babakr AA，et al. Relationship between epicardial adipose tissue thickness and epicardial adipocyte size with increasing body mass index [J]. Adipocyte，2019，8（1）：412-420.
[5] Iacobellis G. Epicardial adipose tissue in contemporary cardiology [J]. Nat Rev Cardiol，2022，19（9）：593-606.
[6] Iacobellis G，Bianco AC. Epicardial adipose tissue：emerging physiological，pathophysiological and clinical features [J]. Trends Endocrinol Metab，2011，22（11）：450-457.
[7] Santoro A，Mcgraw TE，Kahn BB. Insulin action in adipocytes，adipose remodeling，and systemic effects [J]. Cell Metab，2021，33（4）：748-757.
[8] Nerlekar N，Brown AJ，Muthalaly RG，et al. Association of Epicardial Adipose Tissue and High-Risk Plaque Characteristics：A Systematic Review and Meta-Analysis [J]. J Am Heart Assoc，2017，6（8）：e006379.
[9] Mahabadi AA，Rassaf T. Radiomic Assessment of Pericoronary Adipose Tissue：Detecting the Vulnerable Patient [J]. JACC Cardiovasc Imaging，2020，13（11）：2384-2385.
[10] Li Y，Liu B，Li Y，et al. Epicardial fat tissue in patients with diabetes mellitus：a systematic review and meta-analysis [J]. Cardiovasc Diabetol，2019，18（1）：3.
[11] Iacobellis G，Diaz S，Mendez A，et al. Increased epicardial fat and plasma leptin in type 1 diabetes independently of obesity [J]. Nutr Metab Cardiovasc Dis，2014，24 （7）：725- 729.
[12] Yafei S，Elsewy F，Youssef E，et al. Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes [J]. Diab Vasc Dis Res，2019，16（4）：378-384.
[13] Aboukhoudir F，Rekik S，Pansieri M，et al. Adipose epicardial tissue association with subclinical systolic dysfunction detected by longitudinal strain in diabetic patients with poor glycemic control [J]. Ann Cardiol Angeiol（Paris），2018，67（5）：310-314.
[14] Baloglu I，Turkmen K，Selcuk NY，et al. The Relationship Between Visceral Adiposity Index and Epicardial Adipose Tissue in Patients with Type 2 Diabetes Mellitus [J]. Exp Clin Endocrinol Diabetes，2021，129（5）：390-395.
[15] Lima-Martínez MM，Colmenares L，Campanelli Y，et al. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America [J]. Clin Investig Arterioscler，2019，31（1）：15-22.
[16] Kang J，Kim YC，Park JJ，et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins [J]. Cardiovasc Diabetol，2018，17（1）：10.
[17] Gong YY，Peng HY. Correlation analysis of epicardial adipose tissue thickness，C-reactive protein，interleukin-6，visfatin，juxtaposed with another zinc finger protein 1，and type 2 diabetic macroangiopathy [J]. Lipids Health Dis，2021， 20（1）：25.
[18] Liu J，Song G，Meng T，et al. Epicardial adipose tissue thickness as a potential predictor of gestational diabetes mellitus：a prospective cohort study [J]. BMC Cardiovasc Disord，2020，20（1）：184.
[19] Vela-Huerta MM，Amador-Licona N，Domínguez-Damián R，et al. Epicardial fat thickness in infants of diabetic mothers [J]. J Neonatal Perinatal Med，2022，15（1）：75-80.
[20] Wang S，Wang Z，Chen C，et al. Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes [J]. Acta Diabetol，2019，56（9）：1061-1071.
[21] Shao G，Cao Y，Cui Y，et al. Multiparametric CMR imaging of myocardial structure and function changes in diabetic mini-pigs with preserved LV function：a preliminary study [J]. BMC Cardiovasc Disord，2022，22（1）：143.
[22] Pierzynová A，?譒rámek J，Cinkajzlová A，et al. The number and phenotype of myocardial and adipose tissue CD68+ cells is associated with cardiovascular and metabolic disease in heart surgery patients [J]. Nutr Metab Cardiovasc Dis，2019，29（9）：946-955.
[23] Bambace C，Sepe A，Zoico E，et al. Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes [J]. Heart Vessels，2014，29（1）：42-48.
[24] Awazawa M，Ueki K，Inabe K，et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway [J].Cell Metab，2011，13（4）：401-412.
[25] Santiago-Fernández C，Pérez-Belmonte LM，Millán-Gómez M，et al. Overexpression of scavenger receptor and infiltration of macrophage in epicardial adipose tissue of patients with ischemic heart disease and diabetes [J]. J Transl Med，2019，17（1）：95.
[26] Sundara Rajan S，Longhi MP. Dendritic cells and adipose tissue [J]. Immunology，2016，149（4）：353-361.
[27] Mráz M，Cinkajzlová A，Klou■ková J，et al. Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes，Obesity，and Coronary Artery Disease [J]. Mediators Inflamm，2019，2019：5481725.
[28] Camarena V，Sant D，Mohseni M，et al. Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue [J]. Nutr Metab Cardiovasc Dis，2017，27（8）：739-750.
[29] Dozio E，Vianello E，Briganti S，et al. Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat：Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease [J]. J Diabetes Res，2016， 2016：2327341.
[30] Salgado-Somoza A，Teijeira-Fernández E，Fernández AL，et al. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress [J]. Am J Physiol Heart Circ Physiol，2010， 299 （1）：H202-9.
[31] Agra RM，Teijeira-Fernandez E，Pascual-Figal D，et al. Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients [J]. Eur J Clin Invest，2014，44（1）：29-37.
[32] Dozio E，Vianello E，Briganti S，et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation [J]. Int J Cardiol，2014，174（2）：413-414.
[33] Grunewald ZI，Winn NC，Gastecki ML，et al. Removal of interscapular brown adipose tissue increases aortic stiffness despite normal systemic glucose metabolism in mice [J]. Am J Physiol Regul Integr Comp Physiol，2018，314（4）：R584- R597.
[34] Pan JA，Lin H，Yu JY，et al. MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in Diabetes [J]. Oxid Med Cell Longev，2021，2021：9987219.
[35] Kaisanlahti A，Glumoff T. Browning of white fat：agents and implications for beige adipose tissue to type 2 diabetes [J]. J Physiol Biochem，2019，75（1）：1-10.
[36] Moreno-Santos I，Pérez-Belmonte LM，Macías-González M，et al. Type 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery disease [J]. J Transl Med，2016，14（1）：243.
[37] Nasarre L，Juan-Babot O，Gastelurrutia P，et al. Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels [J]. Acta Diabetol，2014，51（1）：23-30.
[38] De Gonzalo-Calvo D，Colom C，Vilades D，et al. Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus [J]. Sci Rep，2018，8（1）：1054.
[39] Barchuk M，Schreier L，López G，et al. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients [J]. Atherosclerosis，2019，288：51-59.
[40] Hong ES，Lim C，Choi HY，et al. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes [J]. BMJ Open Diabetes Res Care，2019，7（1）：e000776.
[41] Burgeiro A，Fuhrmann A，Cherian S，et al. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes [J]. Am J Physiol Endocrinol Metab，2016，310（7）：E550-64.
[42] Fandi?觡o-Vaquero R，Fernández-Trasancos A，Alvarez E，et al. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease [J]. Atherosclerosis，2014，235（2）：281-288.
[43] Liu Y，Fu W，Lu M，et al. Role of miRNAs in Epicardial Adipose Tissue in CAD Patients with T2DM [J]. Biomed Res Int，2016，2016：1629236.
[44] Haberka M，Machnik G，Kowalówka A，et al. Epicardial，paracardial，and perivascular fat quantity，gene expressions，and serum cytokines in patients with coronary artery disease and diabetes [J]. Pol Arch Intern Med，2019，129（11）：738-746.
[45] Jonker JT，De Mol P，De Vries ST，et al. Exercise and type 2 diabetes mellitus：changes in tissue-specific fat distribution and cardiac function [J]. Radiology，2013，269（2）：434- 442.
[46] Christensen RH，Wedell-Neergaard AS，Lehrskov LL，et al. Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues：Secondary Analyses From a Randomized Clinical Trial [J]. JAMA Cardiol，2019，4（8）：778-787.
[47] Gaborit B，Jacquier A，Kober F，et al. Effects of bariatric surgery on cardiac ectopic fat：lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content [J]. J Am Coll Cardiol，2012，60（15）：1381-1389.
[48] Van Schinkel LD，Sleddering MA，Lips MA，et al. Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function [J]. Clin Endocrinol （Oxf），2014， 81（5）：689-695.
[49] Masson W，Lavalle-Cobo A，Nogueira JP. Effect of SGLT2- Inhibitors on Epicardial Adipose Tissue：A Meta-Analysis [J]. Cells，2021，10（8）：2150.
[50] Gaborit B，Ancel P，Abdullah AE，et al. Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes：the EMPACEF study [J]. Cardiovasc Diabetol，2021，20（1）：57.
[51] Zsóri G，Illés D，Ivány E，et al. In New-Onset Diabetes Mellitus，Metformin Reduces Fat Accumulation in the Liver，But Not in the Pancreas or Pericardium [J]. Metab Syndr Relat Disord，2019，17（5）：289-295.
[52] Ziyrek M，Kahraman S，Ozdemir E，et al. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients [J]. Rev Port Cardiol （Engl Ed），2019，38（6）：419-423.
[53] Sardu C，D'onofrio N，Torella M，et al. Pericoronary fat inflammation and Major Adverse Cardiac Events （MACE） in prediabetic patients with acute myocardial infarction：effects of metformin [J]. Cardiovasc Diabetol，2019，18（1）：126.
[54] Iacobellis G，Mohseni M，Bianco SD，et al. Liraglutide causes large and rapid epicardial fat reduction [J]. Obesity （Silver Spring），2017，25（2）：311-316.
[55] Iacobellis G，Camarena V，Sant DW，et al. Human Epicardial Fat Expresses Glucagon-Like Peptide 1 and 2 Receptors Genes [J]. Horm Metab Res，2017，49（8）：625-630.
[56] Dutour A，Abdesselam I，Ancel P，et al. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes：a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy [J]. Diabetes Obes Metab，2016，18（9）：882-891.
[57] Morano S，Romagnoli E，Filardi T，et al. Short-term effects of glucagon-like peptide 1 （GLP-1） receptor agonists on fat distribution in patients with type 2 diabetes mellitus：an ultrasonography study [J]. Acta Diabetol，2015，52（4）：727-732.
[58] González N，Moreno-Villegas Z，González-Bris A，et al. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes [J]. Cardiovasc Diabetol，2017，16（1）：44.
[59] Bizino MB，Jazet IM，De Heer P，et al. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes：a pre-specified secondary study on ectopic fat accumulation [J]. Diabetologia，2020，63（1）：65-74.
[60] Lima-Martínez MM，Paoli M，Rodney M，et al. Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity：a pilot study [J]. Endocrine，2016，51（3）：448-455.
[61] Bao W，Yang M，Xu Z，et al. Coronary Inflammation Assessed by Perivascular Fat Attenuation Index in Patients with Psoriasis：A Propensity Score-Matched Study [J]. Dermatology，2022，238（3）：562-570.
[62] Parisi V，Petraglia L，D'esposito V，et al. Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue [J]. Int J Cardiol，2019，274：326- 330.
[63] Raggi P，Gadiyaram V，Zhang C，et al. Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering：A Potential Pleiotropic Effect [J]. J Am Heart Assoc，2019，8（12）：e013104.
[64] Parisi V. Statin might promote epicardial adipose tissue inflammatory remodeling via NLRP3 suppression：An intriguing hypothesis [J]. Int J Cardiol，2020，300：219.
